Tetracaine

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Tetracaine
Generic name: TETRACAINE
Manufacturer: Bellus Medical, LLC
Product type: HUMAN OTC DRUG
SPL set ID: 60cabb5f-606b-7a74-e053-2a91aa0ac024
SPL ID: 47faba68-aab7-7eb8-e063-6294a90a3931
Version: 4
Effective date: 2026-01-09
Source export date: 2026-09-28
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:49:00

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Tetracaine	openfda.brand_name
generic name		TETRACAINE	openfda.generic_name
manufacturer name		Bellus Medical, LLC	openfda.manufacturer_name
ndc	package	71888-103-01	openfda.package_ndc
ndc	package	71888-103-02	openfda.package_ndc
ndc	product	71888-103	openfda.product_ndc
ndc11	package	71888010301	derived:openfda.package_ndc
ndc11	package	71888010302	derived:openfda.package_ndc
spl id		47faba68-aab7-7eb8-e063-6294a90a3931	id
spl set id		60cabb5f-606b-7a74-e053-2a91aa0ac024	set_id
unii		5NF5D4OPCI	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings : For external use only. Avoid contact with the eyes. DO NOT USE : In large quantities, particularly over raw surfaces and blistered areas. Stop use and ask a doctor if : Skin becomes irritated Condition worsens or symptoms last more than 7 days Symptoms clear up and reoccur within a few days.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.